Teva Pharmaceutical Industries EBIT 2010-2024 | TEVA

Teva Pharmaceutical Industries EBIT for the quarter ending December 31, 2024 was $-0.031B, a 104.11% decline year-over-year.

  • Teva Pharmaceutical Industries 2024 EBIT was -0.303B, a 169.98% decline from 2023.
  • Teva Pharmaceutical Industries 2023 EBIT was 0.433B, a 119.71% decline from 2022.
  • Teva Pharmaceutical Industries 2022 EBIT was -2.197B, a 228.1% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Teva Pharmaceutical Industries EBIT 2010-2024 | TEVA

  • Teva Pharmaceutical Industries 2024 EBIT was -0.303B, a 169.98% decline from 2023.
  • Teva Pharmaceutical Industries 2023 EBIT was 0.433B, a 119.71% decline from 2022.
  • Teva Pharmaceutical Industries 2022 EBIT was -2.197B, a 228.1% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M